Cancer Discovery · 2013 · 74 citations · 41 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingOncogenic Signaling PathwaysSignal Transduction In CancerSoft Tissue SarcomasTargeted Cancer TherapyWnt SignalingBeta-catenin RegulationCanonical Wnt PathwaySynovial Sarcoma TherapyWnt In CancerWnt Signal TransductionWnt Signaling ActivationWnt Signaling DisruptionYoung Adulthood
UNLABELLED: Synovial sarcoma is an aggressive soft-tissue malignancy of children and young adults, with no effective systemic therapies. Its specific oncogene, SYT-SSX (SS18-SSX), drives sarcoma initiation and development. The exact mechanism of SYT-SSX oncogenic function remains unknown. In an SYT-SSX2 transgenic model, we show that a constitutive Wnt/β-catenin signal is aberrantly activated by SYT-SSX2, and inhibition of Wnt signaling through the genetic loss of β-catenin blocks synovial sarcoma tumor formation. In a combination of cell-based and synovial sarcoma tumor xenograft models, we show that inhibition of the Wnt cascade through coreceptor blockade and the use of small-molecule CK1α activators arrests synovial sarcoma tumor growth. We find that upregulation of the Wnt/β-catenin cascade by SYT-SSX2 correlates with its nuclear reprogramming function. These studies reveal the central role of Wnt/β-catenin signaling in SYT-SSX2-induced sarcoma genesis, and open new venues for the development of effective synovial sarcoma curative agents. SIGNIFICANCE: Synovial sarcoma is an aggressive soft-tissue cancer that afflicts children and young adults, and for which there is no effective treatment. The current studies provide critical insight into our understanding of the pathogenesis of SYT–SSX-dependent synovial sarcoma and pave the way for the development of effective therapeutic agents for the treatment of the disease in humans.
41
Paul Polakis · Genes & Development · 2000 · 3.2K citations · Full text
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina, Barry S. Taylor, Shantanu Banerji et al. · Nature Genetics · 2010 · 726 citations · Full text
Molecular characterisation of soft tissue tumours: a gene expression study
Torsten O. Nielsen, Robert B. West, Sabine C. Linn et al. · The Lancet · 2002 · 580 citations
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Ina Krämer, Christine Halleux, H. J. Keller et al. · Molecular and Cellular Biology · 2010 · 571 citations · Full text